litlas
ログインアカウント作成

Manuel Hidalgo

1995–2025 年に発表

173
論文数
49,384
被引用数
106
h 指数
170
i10 指数

被引用数

Manuel Hidalgo の年別被引用数1976 年: 被引用 1 件1985 年: 被引用 1 件1996 年: 被引用 2 件1998 年: 被引用 1 件1999 年: 被引用 5 件2000 年: 被引用 15 件2001 年: 被引用 34 件2002 年: 被引用 79 件2003 年: 被引用 122 件2004 年: 被引用 187 件2005 年: 被引用 254 件2006 年: 被引用 248 件2007 年: 被引用 251 件2008 年: 被引用 276 件2009 年: 被引用 396 件2010 年: 被引用 452 件2011 年: 被引用 501 件2012 年: 被引用 514 件2013 年: 被引用 576 件2014 年: 被引用 580 件2015 年: 被引用 622 件2016 年: 被引用 627 件2017 年: 被引用 680 件2018 年: 被引用 614 件2019 年: 被引用 1,780 件2020 年: 被引用 1,978 件2021 年: 被引用 1,873 件2022 年: 被引用 1,339 件2023 年: 被引用 1,010 件2024 年: 被引用 1,423 件2025 年: 被引用 657 件2026 年: 被引用 21 件1977〜1984 年は被引用が無いため表示していません1986〜1995 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,148 件、この内訳の 28.8%中国: 引用元論文 2,675 件、この内訳の 12.5%イギリス: 引用元論文 1,195 件、この内訳の 5.6%ドイツ: 引用元論文 1,153 件、この内訳の 5.4%イタリア: 引用元論文 1,117 件、この内訳の 5.2%日本: 引用元論文 832 件、この内訳の 3.9%スペイン: 引用元論文 818 件、この内訳の 3.8%フランス: 引用元論文 791 件、この内訳の 3.7%カナダ: 引用元論文 617 件、この内訳の 2.9%オランダ: 引用元論文 578 件、この内訳の 2.7%オーストラリア: 引用元論文 441 件、この内訳の 2.1%スイス: 引用元論文 436 件、この内訳の 2%
0%28.8%その他 21.4%

機関

分野

  • Medicine56.7%
  • Biochemistry, Genetics and Molecular Biology33.1%
  • Immunology and Microbiology3.4%
  • Engineering1.7%
  • Materials Science1.5%
  • Computer Science0.7%
  • その他2.9%

トピック

  • Pancreatic and Hepatic Oncology Research8.9%
  • Cancer Genomics and Diagnostics4.3%
  • Cancer Cells and Metastasis4.2%
  • Epigenetics and DNA Methylation2.3%
  • Lung Cancer Treatments and Mutations2.2%
  • Cancer Immunotherapy and Biomarkers2.2%
  • その他75.9%

共著者

全論文

検索で開く
  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    著者: Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante, Malcolm J. Moore, Thomas E. Seay, Sergei Tjulandin, Wen Wee, Mansoor N. Saleh, Marion Harris, Michele Reni, Scot Dowden, Daniel A. Laheru, Nathan Bahary, Ramesh K. Ramanathan, Josep Tabernero, Manuel Hidalgo, David Goldstein, Eric Van Cutsem, Xinyu Wei, José Iglesias, Markus F. Renschler - New England Journal of Medicine 2013 被引用: 6,661

  2. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    著者: Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, Erkut Borazanci, Brian M. Wolpin, Salomon M. Stemmer, Talia Golan, Ravit Geva, Mitesh J. Borad, Katrina S. Pedersen, Joon Oh Park, Robert A. Ramirez, David Gutiérrez Abad, Jaime Feliú, Andrés Muñoz, Mariano Ponz‐Sarvisé, Amnon Peled, Tzipora M Lustig, Osnat Bohana‐Kashtan, Stephen M. Shaw, Ella Sorani, Marya Chaney, Shaul Kadosh, Abi Vainstein Haras, Daniel D. Von Hoff, Manuel Hidalgo - Nature Medicine 2020 被引用: 533

  3. Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

    著者: Manuel Hidalgo, Frédéric Amant, Andrew V. Biankin, Eva Budínská, Annette T. Byrne, Carlos Caldas, Robert B. Clarke, Steven de Jong, Jos Jonkers, Gunhild M. Mælandsmo, Sergio Roman‐Roman, Joan Seoane, Livio Trusolino, Alberto Villanueva - Cancer Discovery 2014 被引用: 1,760

  4. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

    著者: Siân Jones, Xiaosong Zhang, D. Williams Parsons, Jimmy Lin, Rebecca Leary, Philipp Angenendt, Parminder K. Mankoo, Hannah Carter, Hirohiko Kamiyama, Antonio Jimeno, Seung‐Mo Hong, Baojin Fu, Ming‐Tseh Lin, Eric S. Calhoun, Mihoko Kamiyama, Kimberly Walter, Tatiana Nikolskaya, Yuri Nikolsky, James Hartigan, Douglas R. Smith, Manuel Hidalgo, Steven D. Leach, Alison P. Klein, Elizabeth M. Jaffee, Michael Goggins, Anirban Maitra, Christine A. Iacobuzio–Donahue, James R. Eshleman, Scott E. Kern, Ralph H. Hruban, Rachel Karchin, Nickolas Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E. Velculescu, Kenneth W. Kinzler - Science 2008 被引用: 4,055

  5. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

    著者: David M. Hyman, Igor Puzanov, Vivek Subbiah, Jason E. Faris, Ian Chau, Jean‐Yves Blay, Jürgen Wolf, Noopur Raje, Eli L. Diamond, Antoine Hollebecque, Radj Gervais, Maria Elena Elez-Fernandez, Antoîne Italiano, Ralf‐Dieter Hofheinz, Manuel Hidalgo, Emily Chan, Martin Schüler, Susan Frances Lasserre, Martina Makrutzki, Florin Sirzén, Maria Luisa Veronese, Josep Tabernero, José Baselga - New England Journal of Medicine 2015 被引用: 1,734

  6. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy

    著者: Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu, Nobufumi Sekino, Nami Kim, Theresa Manz, Benika J. Pinch, Dipikaa Akshinthala, Ana Verma, Giorgio Gaglia, Yutaka Nezu, Shizhong Ke, Chenxi Qiu, Kenoki Ohuchida, Yoshinao Oda, Tae Ho Lee, Babara Wegiel, John G. Clohessy, Nir London, Sandro Santagata, Gerburg M. Wulf, Manuel Hidalgo, Senthil K. Muthuswamy, Masafumi Nakamura, Nathanael S. Gray, Xiao Zhen Zhou, Kun Ping Lu - Cell 2021 被引用: 247

  7. Pancreatic Cancer

    著者: Manuel Hidalgo - New England Journal of Medicine 2010 被引用: 2,569

  8. Interrogating open issues in cancer precision medicine with patient-derived xenografts

    著者: Annette T. Byrne, Denis Alférez, Frédéric Amant, Daniela Annibali, Joaquı́n Arribas, Andrew V. Biankin, Alejandra Bruna, Eva Budínská, Carlos Caldas, David K. Chang, Robert B. Clarke, Hans Clevers, George Coukos, Virginie Dangles‐Marie, S. Gail Eckhardt, Eva González‐Suárez, Els Hermans, Manuel Hidalgo, Monika A. Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunhild M. Mælandsmo, Elisabetta Marangoni, Jean‐Christophe Marine, Enzo Médico, Jens Henrik Norum, Héctor G. Pálmer, Daniel S. Peeper, Pier Giuseppe Pelicci, Alejandro Piris‐Giménez, Sergio Roman‐Roman, Oscar M. Rueda, Joan Seoane, Violeta Serra, Laura Soucek, Dominique Vanhecke, Alberto Villanueva, Emilie Vinolo, Andrea Bertotti, Livio Trusolino - Nature reviews. Cancer 2017 被引用: 665

  9. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

    著者: Chris Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido‐Laguna - Nature Reviews Clinical Oncology 2019 被引用: 405

  10. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer

    著者: Joseph E. Grossman, Lakshmi Muthuswamy, Ling Huang, Dipikaa Akshinthala, Sofia Perea, Raul S. Gonzalez, Leo L. Tsai, Jonah Cohen, Bruno Bockorny, Andrea J. Bullock, Benjamin Schlechter, Mary Linton B. Peters, Catherine Conahan, Supraja Narasimhan, Christine Lim, Roger B. Davis, Robert Besaw, Mandeep S. Sawhney, Douglas Pleskow, Tyler M. Berzin, Martin Smith, Tara S. Kent, Mark Callery, Senthil K. Muthuswamy, Manuel Hidalgo - Clinical Cancer Research 2021 被引用: 112

  11. VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects

    著者: Miriam Bazán‐Peregrino, Rocio García‐Carbonero, Berta Laquente, Rafael Álvarez, Ana Mato-Berciano, Marta Giménez-Alejandre, Sara Morgado, Alba Rodríguez-García, María Victoria Maliandi, M Carmen Riesco, Rafael Moreno, Mireia M Ginestà, M Pérez-Carreras, Joan B. Gornals, Susana Prados, Sofía Perea, Gabriel Capellá, Ramón Alemany, Ramón Salazar, E. Blasi, C. Blasco, Manel Cascalló, Manuel Hidalgo - Journal for ImmunoTherapy of Cancer 2021 被引用: 92

  12. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations

    著者: Mandeep Sawhney, Audrey H. Calderwood, Nirav Thosani, Timothy R. Rebbeck, Sachin Wani, Marcia Irene Canto, Douglas S. Fishman, Talia Golan, Manuel Hidalgo, Richard S. Kwon, Douglas L. Riegert‐Johnson, Dushyant V. Sahani, Elena M. Stoffel, Charles M. Vollmer, Bashar Qumseya - Gastrointestinal Endoscopy 2022 被引用: 134

  13. OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models

    著者: Myriam Fabre, Cristina Suárez Ferrer, Saioa Domínguez-Hormaetxe, Bruno Bockorny, Laura Murias, Oliver Seifert, Stephan A. Eisler, Roland E. Kontermann, Klaus Pfizenmaier, So Young Lee, María dM Vivanco, Pedro P. López‐Casas, Sofía Perea, Muhammad Nadeem Abbas, W. Richter, Laureano Simón, Manuel Hidalgo - Clinical Cancer Research 2020 被引用: 102

  14. Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

    著者: Lucia Nogová, Lecia V. Sequist, José Manuel Pérez García, Fabrice André, Jean‐Pierre Delord, Manuel Hidalgo, Jan H.M. Schellens, Philippe A. Cassier, D. Ross Camidge, Martin Schüler, Ulka N. Vaishampayan, Howard A. Burris, Guangming Tian, Mario Campone, Zev A. Wainberg, Wan‐Teck Lim, Patricia LoRusso, Geoffrey I. Shapiro, Katie Parker, Xueying Chen, Somesh Choudhury, François Ringeisen, Diana Graus-Porta, Dale Porter, Randi Isaacs, Reinhard Buettner, Jürgen Wolf - Journal of Clinical Oncology 2017 被引用: 435

  15. Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

    著者: Michele Cioffi, Sara Maria David Trabulo, Manuel Hidalgo, Eithne Costello, William Greenhalf, Mert Erkan, Jörg Kleeff, Bruno Sáinz, Christopher Heeschen - Clinical Cancer Research 2015 被引用: 240

  16. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer

    著者: Jeffrey I. Zwicker, Benjamin L. Schlechter, Jack D. Stopa, Howard A. Liebman, Anita Aggarwal, Mäneka Puligandla, Thomas Caughey, Kenneth A. Bauer, Nancy B. Kuemmerle, Ellice Wong, Ted Wun, Marilyn McLaughlin, Manuel Hidalgo, Donna Neuberg, Bruce Furie, Robert Flaumenhaft, on behalf of CATIQ Investigators - JCI Insight 2019 被引用: 170

  17. Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

    著者: Manuel Hidalgo, Stefano Cascinu, Jörg Kleeff, Roberto Labianca, Matthias Löhr, John P. Neoptolemos, Francisco X. Real, Jean‐Luc Van Laethem, Volker Heinemann - Pancreatology 2014 被引用: 507

  18. Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

    著者: Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Borazanci, Jaime Feliú, Mariano Ponz‐Sarvisé, David Gutiérrez Abad, Paul E. Oberstein, Angela Alistar, Andrés Muñoz, Ravit Geva, Carmen Guillén‐Ponce, Mercedes Salgado Fernández, Amnon Peled, Marya Chaney, Irit Gliko-Kabir, Liron Shemesh-Darvish, Debby Ickowicz, Ella Sorani, Shaul Kadosh, Abi Vainstein‐Haras, Manuel Hidalgo - Clinical Cancer Research 2021 被引用: 88

  19. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

    著者: Eugene Izumchenko, K. Paz, Daniel Ciznadija, Ido Sloma, Amanda Katz, David Vasquez-Dunddel, Ido Ben-Zvi, Justin Stebbing, William P. McGuire, William Proctor Harris, Robert G. Maki, Andrew Gaya, A Bedi, Stergios Zacharoulis, Rajani Ravi, Leonard H. Wexler, Mohammad Obaidul Hoque, Carlos Rodríguez‐Galindo, Harvey I. Pass, Nir Peled, Angela M. Davies, Ronnie Morris, Manuel Hidalgo, D. Sidransky - Annals of Oncology 2017 被引用: 337

  20. PDX-derived organoids model in vivo drug response and secrete biomarkers

    著者: Ling Huang, Bruno Bockorny, Indranil Paul, Dipikaa Akshinthala, Pierre‐Olivier Frappart, Omar Gandarilla, Arindam Bose, Veronica Sanchez‐Gonzalez, Emily E. Rouse, Sylvain Lehoux, Nicole Pandell, Christine Lim, John G. Clohessy, Joseph E. Grossman, Raul S. González, Sofia Perea Del Pino, George Daaboul, Mandeep Sawhney, Steven D. Freedman, Alexander Kleger, Richard D. Cummings, Andrew Emili, Lakshmi Muthuswamy, Manuel Hidalgo, Senthil K. Muthuswamy - JCI Insight 2020 被引用: 130

  21. Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids

    著者: Qingda Meng, Shanshan Xie, G. Kenneth Gray, M Dezfulian, Omar Gandarilla, Weilin Li, Ling Huang, Dipikaa Akshinthala, Elizabeth Ferrer, Catherine Conahan, Sofia Perea Del Pino, Joseph E. Grossman, Stephen J. Elledge, Manuel Hidalgo, Senthil K. Muthuswamy - Journal for ImmunoTherapy of Cancer 2021 被引用: 85

  22. Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

    著者: Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Daniel A. Laheru, Lon Smith, Tina E. Wood, Ronald L. Korn, Neil Desai, Vuong Trieu, J. L. Mesías Iglesias, Hui Zhang, Patrick Soon‐Shiong, Tao Shi, N.V. Rajeshkumar, Anirban Maitra, Manuel Hidalgo - Journal of Clinical Oncology 2011 被引用: 1,045

  23. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

    著者: Rafael Álvarez, Mónica Musteanu, Elena García-García, Pedro P. López‐Casas, Diego Megı́as, Carmen Guerra, Manuel Muñoz, Yolanda Quijano, Antonio Cubillo, Jesús Rodríguez-Pascual, Carlos Plaza, E. Vicente, S. Prados, Susana Tabernero, Mariano Barbacid, Fernando López‐Ríos, Manuel Hidalgo - British Journal of Cancer 2013 被引用: 291

  24. DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

    著者: Christine A. Iacobuzio–Donahue, Baojin Fu, Shinichi Yachida, Mingde Luo, Hisashi Abe, Clark M. Henderson, F Vilardell, Zheng Wang, Jesse W. Keller, Priya R. Banerjee, Joseph M. Herman, John L. Cameron, Charles J. Yeo, Marc K. Halushka, James R. Eshleman, Marian Raben, Alison P. Klein, Ralph H. Hruban, Manuel Hidalgo, Daniel A. Laheru - Journal of Clinical Oncology 2009 被引用: 1,078